Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by barcodewhizon Nov 04, 2004 5:22pm
225 Views
Post# 8138901

There will be many more days like this

There will be many more days like this If management continues its efforts to re-establish confidence in the analyst and institutional community, we will have many more days like this. We are grossly oversold and we are definitely on a lot of people's radar. Everyone is waiting for a catalyst. More than ever that catalyst is imminent from any one of three or four different value pillars in this company. Fund managers, analysts and institutions put a lot of stead in value and risk / reward and I frankly dont think the prospects have ever been better. Remember, most professional money managers are willing to give up the first 25-50% of a stocks move just to be sure that things are moving solidly in the right direction or to have VALIDATION of a business model... Good news from any of Prometic's major initiatives over the next 3-6 months will likely result in a huge re-establishment of institutional positions which translates into a very large move in price.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse